[Form 4] Comerica Incorporated Insider Trading Activity
Comerica executive Allysun C. Fleming reported a sale of 2,100 shares of Comerica Inc. common stock on 08/08/2025 at a reported price of $67.035 per share. After the transaction, Fleming beneficially owned 9,424 shares directly. The Form 4 notes that the reported holdings include shares from employee stock plans, dividend reinvestment and restricted stock units as of the transaction date. The disclosure shows an individual officer sale rather than an acquisition or derivative activity and provides the specific share counts and price paid.
L'esecutiva di Comerica Allysun C. Fleming ha dichiarato la vendita di 2,100 azioni ordinarie di Comerica Inc. il 08/08/2025 a un prezzo riportato di $67.035 per azione. Dopo l'operazione, Fleming possedeva direttamente a titolo beneficiario 9,424 azioni. Il Modulo 4 precisa che le partecipazioni dichiarate includono azioni provenienti da piani azionari per dipendenti, reinvestimento dei dividendi e unità di azioni vincolate alla data della transazione. La comunicazione riguarda una vendita individuale da parte di un dirigente, non un'acquisizione né un'operazione su derivati, e fornisce i conteggi e il prezzo pagato.
La ejecutiva de Comerica, Allysun C. Fleming, informó la venta de 2,100 acciones ordinarias de Comerica Inc. el 08/08/2025 a un precio declarado de $67.035 por acción. Tras la transacción, Fleming poseía directamente a título beneficiario 9,424 acciones. El Formulario 4 señala que las participaciones reportadas incluyen acciones procedentes de planes para empleados, reinversión de dividendos y unidades de acciones restringidas en la fecha de la transacción. La divulgación muestra una venta individual por parte de un directivo, no una adquisición ni actividad con derivados, y aporta los conteos exactos y el precio pagado.
Comerica 임원 Allysun C. Fleming은 08/08/2025에 Comerica Inc. 보통주 2,100주를 주당 보고된 가격인 $67.035에 매각했다고 보고했습니다. 거래 후 Fleming은 직접적으로 9,424주를 실질 보유하고 있었습니다. Form 4는 보고된 보유내역이 거래일 기준 직원 주식 계획, 배당금 재투자 및 제한주식 단위를 포함한다고 명시합니다. 공시는 취득이나 파생상품 거래가 아닌 개별 임원의 매도에 해당하며, 구체적인 주식 수와 거래 가격을 제공합니다.
La dirigeante de Comerica, Allysun C. Fleming, a déclaré la vente de 2,100 actions ordinaires de Comerica Inc. le 08/08/2025 au prix déclaré de $67.035 par action. Après la transaction, Fleming détenait directement à titre bénéficiaire 9,424 actions. Le formulaire 4 précise que les positions déclarées comprennent des actions issues de plans pour employés, du réinvestissement des dividendes et des unités d'actions restreintes à la date de la transaction. La divulgation indique une vente individuelle d'un dirigeant, et non une acquisition ou une opération sur dérivés, en fournissant les nombres d'actions et le prix payé.
Comerica-Managerin Allysun C. Fleming meldete den Verkauf von 2,100 Aktien der Comerica Inc. Stammaktien am 08/08/2025 zu einem gemeldeten Preis von $67.035 pro Aktie. Nach der Transaktion hielt Fleming wirtschaftlich direkt 9,424 Aktien. Formular 4 weist darauf hin, dass die gemeldeten Bestände zum Zeitpunkt der Transaktion Aktien aus Mitarbeiterbeteiligungsplänen, Dividendenausschüttungs-Reinvestitionen und Restricted Stock Units enthalten. Die Offenlegung betrifft einen persönlichen Verkauf eines leitenden Angestellten, keine Erwerbs- oder Derivataktivität, und nennt die genauen Stückzahlen sowie den gezahlten Preis.
- Disclosure completeness: The Form 4 specifies the transaction date, price, quantity sold, and post-transaction holdings.
- Insider retains stake: Reporting person still beneficially owns 9,424 shares, showing continued ownership after sale.
- Compensation clarity: Filing notes holdings include employee stock plans, dividend reinvestment and restricted stock units.
- Insider sale: An officer disposed of 2,100 shares, which is a net reduction in insider ownership.
- No derivative activity disclosed: Absence of offsetting acquisitions or options reduces information about broader position changes.
Insights
TL;DR: Officer sale of 2,100 CMA shares at $67.035, leaving 9,424 shares; transaction is a disclosed insider sale with limited immediate market signal.
As a securities analyst, I view this Form 4 as a routine insider sale disclosure. The transaction code is a sale and the size is explicitly stated: 2,100 shares sold at $67.035, resulting in 9,424 shares held. There is no derivative activity reported. Impact: not impactful to valuation absent broader insider selling trends or material corporate events. The inclusion of employee plans and RSUs clarifies that part of the reported ownership arises from compensation arrangements, which is common for executives.
TL;DR: Disclosure meets Section 16 requirements; sale executed by an officer, ownership remains disclosed and includes compensation-related shares.
From a governance perspective, the filing fulfills required transparency for officer transactions. The report specifies the sale quantity, price, and resulting direct ownership of 9,424 shares and notes that holdings include employee stock plan shares and restricted stock units. There is no indication of a Rule 10b5-1 plan or other contractual plan in the recorded transaction fields. Impact: not impactful on corporate governance standards, but useful for monitoring insider behavior.
L'esecutiva di Comerica Allysun C. Fleming ha dichiarato la vendita di 2,100 azioni ordinarie di Comerica Inc. il 08/08/2025 a un prezzo riportato di $67.035 per azione. Dopo l'operazione, Fleming possedeva direttamente a titolo beneficiario 9,424 azioni. Il Modulo 4 precisa che le partecipazioni dichiarate includono azioni provenienti da piani azionari per dipendenti, reinvestimento dei dividendi e unità di azioni vincolate alla data della transazione. La comunicazione riguarda una vendita individuale da parte di un dirigente, non un'acquisizione né un'operazione su derivati, e fornisce i conteggi e il prezzo pagato.
La ejecutiva de Comerica, Allysun C. Fleming, informó la venta de 2,100 acciones ordinarias de Comerica Inc. el 08/08/2025 a un precio declarado de $67.035 por acción. Tras la transacción, Fleming poseía directamente a título beneficiario 9,424 acciones. El Formulario 4 señala que las participaciones reportadas incluyen acciones procedentes de planes para empleados, reinversión de dividendos y unidades de acciones restringidas en la fecha de la transacción. La divulgación muestra una venta individual por parte de un directivo, no una adquisición ni actividad con derivados, y aporta los conteos exactos y el precio pagado.
Comerica 임원 Allysun C. Fleming은 08/08/2025에 Comerica Inc. 보통주 2,100주를 주당 보고된 가격인 $67.035에 매각했다고 보고했습니다. 거래 후 Fleming은 직접적으로 9,424주를 실질 보유하고 있었습니다. Form 4는 보고된 보유내역이 거래일 기준 직원 주식 계획, 배당금 재투자 및 제한주식 단위를 포함한다고 명시합니다. 공시는 취득이나 파생상품 거래가 아닌 개별 임원의 매도에 해당하며, 구체적인 주식 수와 거래 가격을 제공합니다.
La dirigeante de Comerica, Allysun C. Fleming, a déclaré la vente de 2,100 actions ordinaires de Comerica Inc. le 08/08/2025 au prix déclaré de $67.035 par action. Après la transaction, Fleming détenait directement à titre bénéficiaire 9,424 actions. Le formulaire 4 précise que les positions déclarées comprennent des actions issues de plans pour employés, du réinvestissement des dividendes et des unités d'actions restreintes à la date de la transaction. La divulgation indique une vente individuelle d'un dirigeant, et non une acquisition ou une opération sur dérivés, en fournissant les nombres d'actions et le prix payé.
Comerica-Managerin Allysun C. Fleming meldete den Verkauf von 2,100 Aktien der Comerica Inc. Stammaktien am 08/08/2025 zu einem gemeldeten Preis von $67.035 pro Aktie. Nach der Transaktion hielt Fleming wirtschaftlich direkt 9,424 Aktien. Formular 4 weist darauf hin, dass die gemeldeten Bestände zum Zeitpunkt der Transaktion Aktien aus Mitarbeiterbeteiligungsplänen, Dividendenausschüttungs-Reinvestitionen und Restricted Stock Units enthalten. Die Offenlegung betrifft einen persönlichen Verkauf eines leitenden Angestellten, keine Erwerbs- oder Derivataktivität, und nennt die genauen Stückzahlen sowie den gezahlten Preis.
FAQ
What insider transaction was reported for Comerica (CMA)?
How many Comerica (CMA) shares does the reporting person own after the sale?
Does the Form 4 indicate the source of the reported shares?
Was the transaction an acquisition or a sale?
Does the Form 4 show use of a 10b5-1 trading plan?
